A compound of Formula: wherein R 1 is C 1-4 alkyl or C 1-4 haloalkyl; is wherein m, n, o, and p are each independently 1 or 2; and wherein is optionally substituted with one, two, and three R 2 members; wherein each R 2 is independently H, halo, OH, C 1-4 alkyl, or OC 1-4 alkyl; L is a bond, C 1-4 alkyl, C 1-4 haloalkyl, or O; and R 3 is: (a) phenyl optionally substituted with one, two or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, N(C 1-4 alkyl) 2, pyrrolidinyl, C 3-6 cycloalkyl, OC 3-6 cycloalkyl, 1H-pyrazol-1-yl, and 1-methyl-1H-imidazol-4-yl; (b) a 6-membered heteroaryl optionally substituted with one, two, or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, C 3-6 cycloalkyl, and C 3-6 cycloalkyl substituted with C 1-4 alkyl or C 1-4 haloalkyl; (c) a 5-membered heteroaryl optionally substituted with one, two, or three members each independently selected from C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, and phenyl; (d) a fused 5-6 heteroaryl or a fused 6-6 heteroaryl each optionally substituted with one, two, or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, and OC 1-4 haloalkyl; or (e) 2,3-dihydro-1H-indenyl, 2,3-dihydrobenzofuranyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,5-a]pyridinyl, or 6,7-dihydro-5H-cyclopenta[b]pyridinyl; or a pharmaceutically acceptable salt, isotope, N-oxide, solvate, or stereoisomer thereof. R 1 is C 1-4 alkyl or C 1-4 haloalkyl; is wherein m, n, o, and p are each independently 1 or 2; and wherein is optionally substituted with one, two, and three R 2 members; wherein each R 2 is independently H, halo, OH, C 1-4 alkyl, or OC 1-4 alkyl; wherein m, n, o, and p are each independently 1 or 2; and wherein is optionally substituted with one, two, and three R 2 members; wherein each R 2 is independently H, halo, OH, C 1-4 alkyl, or OC 1-4 alkyl; L is a bond, C 1-4 alkyl, C 1-4 haloalkyl, or O; and R 3 is: (a) phenyl optionally substituted with one, two or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, N(C 1-4 alkyl) 2, pyrrolidinyl, C 3-6 cycloalkyl, OC 3-6 cycloalkyl, 1H-pyrazol-1-yl, and 1-methyl-1H-imidazol-4-yl; (b) a 6-membered heteroaryl optionally substituted with one, two, or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, C 3-6 cycloalkyl, and C 3-6 cycloalkyl substituted with C 1-4 alkyl or C 1-4 haloalkyl; (c) a 5-membered heteroaryl optionally substituted with one, two, or three members each independently selected from C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, and phenyl; (d) a fused 5-6 heteroaryl or a fused 6-6 heteroaryl each optionally substituted with one, two, or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, and OC 1-4 haloalkyl; or (e) 2,3-dihydro-1H-indenyl, 2,3-dihydrobenzofuranyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,5-a]pyridinyl, or 6,7-dihydro-5H-cyclopenta[b]pyridinyl; (a) phenyl optionally substituted with one, two or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, N(C 1-4 alkyl) 2, pyrrolidinyl, C 3-6 cycloalkyl, OC 3-6 cycloalkyl, 1H-pyrazol-1-yl, and 1-methyl-1H-imidazol-4-yl; (b) a 6-membered heteroaryl optionally substituted with one, two, or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, C 3-6 cycloalkyl, and C 3-6 cycloalkyl substituted with C 1-4 alkyl or C 1-4 haloalkyl; (c) a 5-membered heteroaryl optionally substituted with one, two, or three members each independently selected from C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, OC 1-4 haloalkyl, and phenyl; (d) a fused 5-6 heteroaryl or a fused 6-6 heteroaryl each optionally substituted with one, two, or three members each independently selected from halo, C 1-4 alkyl, C 1-4 haloalkyl, OC 1-4 alkyl, and OC 1-4 haloalkyl; or (e) 2,3-dihydro-1H-indenyl, 2,3-dihydrobenzofuranyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,5-a]pyridinyl, or 6,7-dihydro-5H-cyclopenta[b]pyridinyl; or a pharmaceutically acceptable salt, isotope, N-oxide, solvate, or stereoisomer thereof.